Human NLRC4 expression promotes cancer survival and associates with type I interferon signaling and immune infiltration.
Domblides C, Crampton S, Liu H, Bartleson JM, Nguyen A, Champagne C, Landy EE, Spiker L, Proffitt C, Bhattarai S, Grawe AP, Fuentealba Valenzuela M, Lartigue L, Mahouche I, Dupaul-Chicoine J, Nishimura K, Lefort F, Decraecker M, Velasco V, Netzer S, Pitard V, Roy C, Soubeyran I, Racine V, Blanco P, Déchanet-Merville J, Saleh M, Canna SW, Furman D, Faustin B.
Domblides C, et al. Among authors: canna sw.
J Clin Invest. 2024 Apr 23;134(11):e166085. doi: 10.1172/JCI166085.
J Clin Invest. 2024.
PMID: 38652550
Free PMC article.